Helsinn and Recordati Rare Diseases to announce satellite symposium on advances in Mycosis Fungoides-Cutaneous T cell Lymphoma (MF-CTCL) treatment at the 49th European Society for Dermatological Research Annual Meeting 2019

19 September 2019

Helsinn and Lyfebulb Announce Call for Applications for Third Annual Patient-Driven Innovation Summit & Award in Oncology

17 September 2019

Augusto Mitidieri awarded as “Most Innovative Pharmaceutical CEO – Europe 2019”

17 September 2019

Helsinn and Mundipharma China Pharmaceutical jointly announce NMPA’s approval of the oral formulation of Akynzeo® in China

16 September 2019

APR presents new data at SSIEM Annual Symposium showing benefits of PKU GOLIKE® in PKU management

4 September 2019

CPhI Worldwide 2019 – Frankfurt, 5-7 November 2019

3 September 2019

Helsinn signs exclusive distribution and license agreements with Blanver and Varifarma for Pracinostat in South America

2 September 2019

Helsinn and Lyfebulb Announce Third Annual Patient-Driven Innovation Summit & Award in Oncology to be held during the 14th Monaco Biennale of Oncology 2020

30 August 2019

Helsinn and Endo Announce Agreement for Paladin Labs Inc. to Commercialize Pracinostat in Canada

31 July 2019

Helsinn Investment Fund Announces First Exit

15 July 2019